Global Critical Care Diagnostics Market 2018-2022

救命救急診療の世界市場2018-2022

◆タイトル:Global Critical Care Diagnostics Market 2018-2022
◆商品コード:IRTNTR21050
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年3月22日
◆ページ数:128
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:In-vitro Diagnostics
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、救命救急診療の世界市場について調査・分析し、市場概要、市場環境、救命救急診療市場規模、用途別(微生物検査・感染症検査、血液検査、心臓検査・脂質検査、血液凝固検査、血糖検査、便潜血検査、その他)分析、最終用途別分析、市場動向、競争環境、主要地域別市場規模(アメリカ、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・救命救急診療の世界市場概要
・救命救急診療の世界市場環境
・救命救急診療の世界市場動向
・救命救急診療の世界市場規模
・救命救急診療の世界市場:業界構造分析
・救命救急診療の世界市場:用途別(微生物検査・感染症検査、血液検査、心臓検査・脂質検査、血液凝固検査、血糖検査、便潜血検査、その他)
・救命救急診療の世界市場:最終用途別
・救命救急診療の世界市場:地域別市場規模・分析
・救命救急診療のアメリカ市場規模・予測
・救命救急診療のヨーロッパ市場規模・予測
・救命救急診療のアジア市場規模・予測
・救命救急診療の主要国分析
・救命救急診療の世界市場:意思決定フレームワーク
・救命救急診療の世界市場:成長要因、課題
・救命救急診療の世界市場:競争環境
・救命救急診療の世界市場:関連企業情報(ベンダー分析)

About Critical Care Diagnostics
Critical Care Diagnostics are used to treat patients with life-threatening conditions. Critical care diagnostic products are used to treat patients in emergency care units, critical care units and ICUs.
Technavio’s analysts forecast Global Critical Care Diagnostics market to grow at a CAGR of 6.35% from 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the Global Critical Care Diagnostics market for the period 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Critical Care Diagnostics 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abbott
• BD
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
• Siemens Healthcare

Market driver
• Growing focus on diagnosis of chronic conditions and infectious diseases
• For a full, detailed list, view our report

Market challenge
• Lack of skilled professionals
• For a full, detailed list, view our report

Market trend
• The adoption of next-generation technology
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Microbial and infectious disease testing – Market size and forecast 2017-2022
• Hematology testing – Market size and forecast 2017-2022
• Cardiac and lipid testing – Market size and forecast 2017-2022
• Coagulation testing – Market size and forecast 2017-2022
• Blood glucose testing – Market size and forecast 2017-2022
• Fecal occult testing – Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Data management and connectivity to EHRs through interoperability
• Focus on next-generation technologies
• Increasing online marketing of critical care diagnostics
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive landscape
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• bioMérieux
• Danaher
• F. Hoffmann-La Roche
• Siemens Healthcare
• Other prominent vendors
PART 16: APPENDIX
• List of abbreviations

Exhibit 01: Parent market
Exhibit 02: Global IVD market segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Application – Market share 2017-2022 (%)
Exhibit 19: Comparison by application
Exhibit 20: Microbial and infectious disease testing – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Microbial and infectious disease testing – Year-over-year growth 2018-2022 (%)
Exhibit 22: Hematology testing – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Hematology testing – Year-over-year growth 2018-2022 (%)
Exhibit 24: Cardiac and lipid testing – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Cardiac and lipid testing – Year-over-year growth 2018-2022 (%)
Exhibit 26: Coagulation testing – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Coagulation testing – Year-over-year growth 2018-2022 (%)
Exhibit 28: Blood glucose testing – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Blood glucose testing – Year-over-year growth 2018-2022 (%)
Exhibit 30: Fecal occult testing – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Fecal occult testing – Year-over-year growth 2018-2022 (%)
Exhibit 32: Others – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Others – Year-over-year growth 2018-2022 (%)
Exhibit 34: Market opportunity by application
Exhibit 35: Customer landscape
Exhibit 36: Global critical care diagnostics market by end-users – Market share (%)
Exhibit 37: Global – Market share by geography 2017-2022 (%)
Exhibit 38: Regional comparison
Exhibit 39: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 40: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 41: Top three countries in Americas
Exhibit 42: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 43: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 44: Top three countries in EMEA
Exhibit 45: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 46: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 47: Top three countries in APAC
Exhibit 48: Market opportunity
Exhibit 49: M&A activities
Exhibit 50: Vendor landscape
Exhibit 51: Landscape disruption
Exhibit 52: Vendors covered
Exhibit 53: Vendor classification
Exhibit 54: Market positioning of vendors
Exhibit 55: Abbott – Overview
Exhibit 56: Abbott – Business segments
Exhibit 57: Abbott – Organizational developments
Exhibit 58: Abbott – Geographic focus
Exhibit 59: Abbott – Segment focus
Exhibit 60: Abbott – Key offerings
Exhibit 61: Abbott – Key customers
Exhibit 62: BD – Overview
Exhibit 63: BD – Business segments
Exhibit 64: BD – Organizational developments
Exhibit 65: BD – Geographic focus
Exhibit 66: BD – Segment focus
Exhibit 67: BD – Key offerings
Exhibit 68: BD – Key customers
Exhibit 69: bioMérieux – Overview
Exhibit 70: bioMérieux – Business segments
Exhibit 71: bioMérieux – Organizational developments
Exhibit 72: bioMérieux – Geographic focus
Exhibit 73: bioMérieux – Segment focus
Exhibit 74: bioMérieux – Key offerings
Exhibit 75: bioMérieux – Key customers
Exhibit 76: Danaher – Overview
Exhibit 77: Danaher – Business segments
Exhibit 78: Danaher – Organizational developments
Exhibit 79: Danaher – Geographic focus
Exhibit 80: Danaher – Segment focus
Exhibit 81: Danaher – Key offerings
Exhibit 82: Danaher – Key customers
Exhibit 83: F. Hoffmann-La Roche – Overview
Exhibit 84: F. Hoffmann-La Roche – Business segments
Exhibit 85: F. Hoffmann-La Roche – Organizational developments
Exhibit 86: F. Hoffmann-La Roche – Geographic focus
Exhibit 87: F. Hoffmann-La Roche – Segment focus
Exhibit 88: F. Hoffmann-La Roche – Key offerings
Exhibit 89: F. Hoffmann-La Roche – Key customers
Exhibit 90: Siemens Healthcare – Overview
Exhibit 91: Siemens Healthcare – Business segments
Exhibit 92: Siemens Healthcare – Organizational developments
Exhibit 93: Siemens Healthcare – Geographic focus
Exhibit 94: Siemens Healthcare – Segment focus
Exhibit 95: Siemens Healthcare – Key offerings
Exhibit 96: Siemens Healthcare – Key customers



【掲載企業】

Abbott
BD
bioMérieux
Danaher
F. Hoffmann-La Roche
Siemens Healthcare

★調査レポート[救命救急診療の世界市場2018-2022] (Global Critical Care Diagnostics Market 2018-2022 / IRTNTR21050)販売に関する免責事項
[救命救急診療の世界市場2018-2022] (Global Critical Care Diagnostics Market 2018-2022 / IRTNTR21050)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆